PTPN11 mutations are associated with poor outcomes across myeloid malignancies.
David M SwobodaNajla Al AliOnyee ChanEric PadronAndrew T KuykendallJinming SongMohammad HussainiChetasi TalatiKendra SweetJeffrey E LancetDavid A SallmanRami S KomrokjiPublished in: Leukemia (2020)